Drug Shortage Report for REVATIO
| Report ID | 63649 |
| Drug Identification Number | 02341611 |
| Brand name | REVATIO |
| Common or Proper name | REVATIO |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | SILDENAFIL |
| Strength(s) | 0.8MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1x 12.5ML VIAL |
| ATC code | C02KX |
| ATC description | OTHER ANTIHYPERTENSIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-10-09 |
| Estimated end date | |
| Actual end date | 2018-12-17 |
| Shortage status | Resolved |
| Updated date | 2018-12-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-10-10 | English | Compare |
| v2 | 2018-10-10 | English | Compare |
| v3 | 2018-10-10 | French | Compare |
| v4 | 2018-12-13 | English | Compare |
| v5 | 2018-12-13 | French | Compare |
| v6 | 2018-12-17 | English | Compare |
| v7 | 2018-12-17 | English | Compare |
| v8 | 2018-12-17 | French | Compare |
| v9 | 2018-12-18 | English | Compare |
Showing 1 to 9 of 9